TORONTO, Jan. 30, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel cannabinoid solutions, today announced the advancement of the research … Read More
The post Revive Therapeutics Advances Research Program of Cannabinoid -Based Therapies Targeting … appeared first on Dagga Magazine.